Your browser doesn't support javascript.
loading
Performance of commercial SARS-CoV-2 wild-type and Omicron BA.1 antibody assays compared with pseudovirus neutralization tests.
Habermann, E; Frommert, L M; Ghannam, K; Nguyen My, L; Gieselmann, L; Tober-Lau, P; Klotsche, J; Arumahandi de Silva, A N; Ten Hagen, A; Zernicke, J; Kurth, F; Sander, L E; Klein, F; Burmester, G R; Biesen, R; Albach, F N.
Affiliation
  • Habermann E; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Frommert LM; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Ghannam K; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Nguyen My L; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Gieselmann L; Laboratory of Experimental Immunology, Institute of Virology, University Hospital Cologne, Cologne, Germany.
  • Tober-Lau P; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Klotsche J; German Rheumatism Research Center Berlin - a Leibniz Institute (DRFZ), Berlin, Germany.
  • Arumahandi de Silva AN; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Ten Hagen A; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Zernicke J; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Kurth F; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Sander LE; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Klein F; Laboratory of Experimental Immunology, Institute of Virology, University Hospital Cologne, Cologne, Germany.
  • Burmester GR; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Biesen R; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Albach FN; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Electronic address: fredrik.albach@charite.de.
J Clin Virol ; 165: 105518, 2023 08.
Article in En | MEDLINE | ID: mdl-37354690
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA Viruses / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA Viruses / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2023 Type: Article Affiliation country: Germany